Skip to main content Accessibility help
×
Home

Attitudes towards pharmacotherapy in late-life bipolar disorder

  • Soham Rej (a1), Josien Schuurmans (a2), Dominique Elie (a3), Max L. Stek (a2), Kenneth Shulman (a1) and Annemiek Dols (a2)...

Abstract

Background:

Lithium remains a first-line treatment for bipolar disorder, but clinicians have considerable concern over potential adverse effects, especially in older adults. Older patients’ attitude towards lithium has not been investigated, even though negative attitudes are closely associated with reduced adherence. We examine the attitude towards lithium pharmacotherapy in older adults with bipolar disorder.

Methods:

In a cross-sectional study of 78 patients aged >60 years with bipolar disorder, the association between lithium use and attitudes towards psychotropic pharmacotherapy was assessed using the Drug Attitude Inventory (DAI-10), including multivariate analyses.

Results:

Compared to patients using alternative psychopharmacological treatments (n =30), lithium users (n=48) showed higher self-reported contentedness, subjective somatic health, and social functioning scores. Although 58.7% of lithium users reported severe adverse effects, lithium users had more positive attitudes towards psychotropic pharmacotherapy compared to non-users (DAI-10 mean score 6.0 vs. 3.9, p =0.01), and this effect was independent of potential confounders.

Conclusions:

Older bipolar patients using lithium have a more positive attitude towards psychotropic pharmacotherapy, despite high rates of adverse effects. Future longitudinal studies could investigate whether positive medication attitudes lead to improved treatment adherence and reduced bipolar disorder relapse in older lithium users.

Copyright

Corresponding author

Correspondence should be addressed to: Soham Rej, MD, MSc, Division of Geriatric Psychiatry, Sunnybrook Health Sciences Centre, University of Toronto, 2075 Baycrest Avenue, Room FG-08, Toronto, ON, M4N 3M5, Canada. Phone: +(416) 480-6133; Fax: +(416) 480-5070. Email: soham.rej@mail.mcgill.ca.

References

Hide All
American Psychiatric, A., American Psychiatric, A. and Task Force on, D.-I. (2000). Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association.
Arvilommi, P., Suominen, K., Mantere, O., Leppamaki, S., Valtonen, H. and Isometsa, E. (2014). Predictors of adherence to psychopharmacological and psychosocial treatment in bipolar I or II disorders – an 18-month prospective study. Journal of Affective Disorders, 155, 110117.
Awad, A. G. (1993). Subjective response to neuroleptics in schizophrenia. Schizophrenia Bulletin, 19, 609618.
Baldessarini, R. J., Leahy, L., Arcona, S., Gause, D., Zhang, W. and Hennen, J. (2007). Patterns of psychotropic drug prescription for US patients with diagnoses of bipolar disorders. Psychiatric Services, 58, 8591.
Carney, S. M. and Goodwin, G. M. (2005). Lithium – a continuing story in the treatment of bipolar disorder. Acta psychiatrica Scandinavica. Supplementum, 426, 712.
Chang, C. W., Sajatovic, M. and Tatsuoka, C. (2014). Correlates of attitudes towards mood stabilizers in individuals with bipolar disorder. Bipolar Disorders, 17, 106112.
Dols, A., Rhebergen, D., Beekman, A., Kupka, R., Sajatovic, M. and Stek, M. L. (2014). Psychiatric and medical comorbidities: results from a bipolar elderly cohort study. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 22, 10661074.
Dols, A. et al. (2013). The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective: a review. International Clinical Psychopharmacology, 28, 287296.
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.
Geddes, J. R. et al. (2010). Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet, 375, 385395.
Ghose, K. (1991). The need for a review journal of drug use and the elderly. Drugs & Aging, 1, 25.
Grof, P. (2010). Sixty years of lithium responders. Neuropsychobiology, 62, 816.
Hayes, J. et al. (2011). Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995–2009. PloS one, 6, e28725.
Kessing, L. V., Hansen, H. V. and Bech, P. (2006). Attitudes and beliefs among patients treated with mood stabilizers. Clinical Practice and Epidemiology in Mental Health, 2, 8.
Kessing, L. V., Hellmund, G., Geddes, J. R., Goodwin, G. M. and Andersen, P. K. (2011). Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. The British Journal of Psychiatry : The Journal of Mental Science, 199, 5763.
Kriegsman, D. M., Penninx, B. W., van Eijk, J. T., Boeke, A. J. and Deeg, D. J. (1996). Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. Journal of Clinical Epidemiology, 49, 14071417.
McKnight, R. F., Adida, M., Budge, K., Stockton, S., Goodwin, G. M. and Geddes, J. R. (2012). Lithium toxicity profile: a systematic review and meta-analysis. Lancet, 379, 721728.
Miura, T. et al. (2014). Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis. The Lancet Psychiatry, 1, 351359.
Pompili, M. et al. (2013). Mood disorders medications: predictors of nonadherence – review of the current literature. Expert Review of Neurotherapeutics, 13, 809825.
Priebe, S., Huxley, P., Knight, S. and Evans, S. (1999). Application and results of the manchester short assessment of quality of life (MANSA). International Journal of Social Psychiatry, 45, 712.
Radloff, L. S. (1977). The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385401.
Rej, S., Elie, D., Mucsi, I., Looper, K. J. and Segal, M. (2015). Chronic kidney disease in lithium-treated older adults: a review of epidemiology, mechanisms, and implications for the treatment of late-life mood disorders. Drugs & Aging, 32, 3142.
Rej, S. et al. (2014). Prevalence and correlates of renal disease in older lithium users: a population-based study. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 22, 10751082.
Renes, J. W., Regeer, E. J., van der Voort, T. Y., Nolen, W. A. and Kupka, R. W. (2014). Treatment of bipolar disorder in the Netherlands and concordance with treatment guidelines: study protocol of an observational, longitudinal study on naturalistic treatment of bipolar disorder in everyday clinical practice. BMC Psychiatry, 14, 58.
Rosa, A. R., Marco, M., Fachel, J. M., Kapczinski, F., Stein, A. T. and Barros, H. M. (2007). Correlation between drug treatment adherence and lithium treatment attitudes and knowledge by bipolar patients. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 31, 217224.
Selle, V., Schalkwijk, S., Vazquez, G. H. and Baldessarini, R. J. (2014). Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics. Pharmacopsychiatry, 47, 4352.
Sheehan, D. V. et al. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59, 3457.
Shulman, K. I. et al. (2003). Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ, 326, 960961.
Simhandl, C., Konig, B. and Amann, B. L. (2014). A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients. The Journal of Clinical Psychiatry, 75, 254262.
Strejilevich, S. A. et al. (2011). Clinical concepts associated with lithium underutilization in the treatment of bipolar disorder. Vertex, 22, 320.
van Vliet, I. M. and de Beurs, E. (2007). The MINI-international neuropsychiatric interview. A brief structured diagnostic psychiatric interview for DSM-IV en ICD-10 psychiatric disorders. Tijdschrift voor Psychiatry, 49, 393397.
Wilting, I., Heerdink, E. R., Mersch, P. P., den Boer, J. A., Egberts, A. C. and Nolen, W. A. (2009). Association between lithium serum level, mood state, and patient-reported adverse drug reactions during long-term lithium treatment: a naturalistic follow-up study. Bipolar Disorders, 11, 434440.
Yatham, L. N. et al. (2013). Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disorders, 15, 144.
Young, R. C., Biggs, J. T., Ziegler, V. E. and Meyer, D. A. (1978). A rating scale for mania: reliability, validity and sensitivity. The British Journal of Psychiatry: The Journal of Mental Science, 133, 429435.

Keywords

Attitudes towards pharmacotherapy in late-life bipolar disorder

  • Soham Rej (a1), Josien Schuurmans (a2), Dominique Elie (a3), Max L. Stek (a2), Kenneth Shulman (a1) and Annemiek Dols (a2)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed